Go Life, Elysium deal expands market to 2.5bn people

Go Life International announced on Tuesday that it had agreed a strategic partnership with Elysium Healthcare that would enable the two companies to reach an estimated 2.5 billion people across 25 countries. Go Life, an integrated life sciences group with a range of patented technologies, products, ingredients and proprietary formulas in the nutraceuticals and cosmeceuticals markets, said the agreement meant it would add generic and pharmaceutical medicine to its range and expand its market potential to an additional 13 African countries, as well as India.